Association of MEF2A and SLC22A3-LPAL2-LPA polymorphisms with warfarin sensitivity during the initiation phase of therapy of 212 warfarin-treated cardiovascular patients.

التفاصيل البيبلوغرافية
العنوان: Association of MEF2A and SLC22A3-LPAL2-LPA polymorphisms with warfarin sensitivity during the initiation phase of therapy of 212 warfarin-treated cardiovascular patients.
المؤلفون: Laith N. AL-Eitan, Ayah Y. Almasri, Adan H. Alnaamneh, Ahmad Mihyar
سنة النشر: 2023
مصطلحات موضوعية: Cell Biology, Genetics, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, genes may help, 213 healthy controls, lpa gene cluster, needed warfarin dose, adverse drug effects, cardiovascular disease susceptibility, lpa gene polymorphisms, moderate warfarin sensitivity, cardiovascular disease, lpa rs10455872, lpa <, healthy individuals, mef2a gene, cardiovascular patients, warfarin sensitivity, warfarin metabolism, warfarin medication, warfarin efficiency, %22">xlink ">, study aims, significant differences
الوصف: Association of MEF2A and SLC22A3-LPAL2-LPA polymorphisms with warfarin sensitivity during the initiation phase of therapy of 212 warfarin-treated cardiovascular patients.
نوع الوثيقة: dataset
اللغة: unknown
Relation: https://figshare.com/articles/dataset/Association_of_i_MEF2A_i_and_i_SLC22A3-LPAL2-LPA_i_polymorphisms_with_warfarin_sensitivity_during_the_initiation_phase_of_therapy_of_212_warfarin-treated_cardiovascular_patients_/24544165
DOI: 10.1371/journal.pone.0294226.t002
الاتاحة: https://doi.org/10.1371/journal.pone.0294226.t002
https://figshare.com/articles/dataset/Association_of_i_MEF2A_i_and_i_SLC22A3-LPAL2-LPA_i_polymorphisms_with_warfarin_sensitivity_during_the_initiation_phase_of_therapy_of_212_warfarin-treated_cardiovascular_patients_/24544165
Rights: CC BY 4.0
رقم الانضمام: edsbas.71571CEE
قاعدة البيانات: BASE
الوصف
DOI:10.1371/journal.pone.0294226.t002